Fuse Science, Inc.
DROP · OTC
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | -3.25 | 0.00 |
| FCF Yield | 0.00% | 0.00% | 0.37% | 0.35% |
| EV / EBITDA | 0.00 | 0.00 | 316.96 | 283.72 |
| Quality | ||||
| ROIC | 0.00% | 0.00% | 13.18% | 99.98% |
| Gross Margin | 0.00% | 0.00% | 100.00% | 99.43% |
| Cash Conversion Ratio | 1.20 | – | 0.06 | 0.24 |
| Growth | ||||
| Revenue 3-Year CAGR | -51.15% | 30.04% | – | -60.88% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.61% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 0.00 | -7.79 | -1.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |